Article info

Download PDFPDF
Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

Authors

  1. Address correspondence and reprint requests to: Michael Friedlander, MD, PhD, Prince of Wales Hospital, High Street, Randwick, New South Wales 2036, Australia. Email: Michael.Friedlander{at}sesiahs.health.nsw.gov.au

Citation

Friedlander M, Buck M, Wyld D, et al
Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

Publication history

  • First published February 1, 2007.
Online issue publication 
March 05, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.